Advanced

Pharmaceutical priority setting and the use of health economic evaluations: a systematic literature review.

Erntoft, Sandra LU (2011) In Value in Health 14(4). p.587-599
Abstract
To investigate which factors and criteria are used in priority setting of pharmaceuticals, in what contexts health economic evaluations are used, and barriers to the use of health economic evaluations at micro, meso, and macro health-care levels.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Value in Health
volume
14
issue
4
pages
587 - 599
publisher
Wiley-Blackwell
external identifiers
  • wos:000299080800025
  • pmid:21669384
  • scopus:79960013935
ISSN
1098-3015
DOI
10.1016/j.jval.2010.10.036
language
English
LU publication?
yes
id
74c5518d-1dac-499a-8f4e-e18627546d8f (old id 2008118)
date added to LUP
2011-07-25 10:31:40
date last changed
2017-08-13 03:08:24
@article{74c5518d-1dac-499a-8f4e-e18627546d8f,
  abstract     = {To investigate which factors and criteria are used in priority setting of pharmaceuticals, in what contexts health economic evaluations are used, and barriers to the use of health economic evaluations at micro, meso, and macro health-care levels.},
  author       = {Erntoft, Sandra},
  issn         = {1098-3015},
  language     = {eng},
  number       = {4},
  pages        = {587--599},
  publisher    = {Wiley-Blackwell},
  series       = {Value in Health},
  title        = {Pharmaceutical priority setting and the use of health economic evaluations: a systematic literature review.},
  url          = {http://dx.doi.org/10.1016/j.jval.2010.10.036},
  volume       = {14},
  year         = {2011},
}